{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-002130","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.231875+00:00","generated_at":"2026-05-29T00:10:30.512178+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Lipella Pharma special meeting adjourned due to lack of quorum; reconvenes Dec 27","bullets":["Special meeting on Dec 20, 2024 lacked a quorum; adjourned to Dec 27, 2024 at 2:00 p.m. ET.","Valid proxies submitted before original meeting remain valid for reconvened meeting unless revoked.","No proposals were voted on; meeting was virtual.","Company filed definitive proxy statement on Nov 12, 2024 for the special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-002130","json":"https://secwatch.observer/filing/0001753926-24-002130.json","markdown":"https://secwatch.observer/filing/0001753926-24-002130.md","text":"https://secwatch.observer/filing/0001753926-24-002130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624002130/0001753926-24-002130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624002130/g084611_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:10:30.512178+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}